Lansdowne Partners
https://www.lansdownepartners.com/Lansdowne Partners, a global alternative investment firm, invests in the public equity and alternative markets of the United States and United Kingdom. Lansdowne Partners was founded in 1998.
View More Recent Stories
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Mar 31
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Mar 31
-
Billion-Dollar Businesses Sign Up to Change Investment for the Better
-
ATP Denmark's CIO Henrik Gade Jepsen Announced as Institutional Investor's Lifetime Achievement Award Recipient for Inaugural European Awards
-
Eisai and Genomics Plc to Collaborate in Analyses of Large-Scale Genotype/Phenotype Data to Inform Drug Development
-
Eisai and Genomics plc to Collaborate in Analyses of Large-Scale Genotype/Phenotype Data to Inform Drug Development
-
Form SC 13D/A Summit Therapeutics plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form SC 13D Summit Therapeutics plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form SC 13G/A Manchester United plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form SC 13G/A Alexza Pharmaceuticals Filed by: LANSDOWNE PARTNERS AUSTRIA GMBH
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Dec 31
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Dec 31
-
Morgan Stanley (MS) Latest to Cut Hedge Fund Exposure as Banking Regulatory Pressures Mount
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Sep 30
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Sep 30
-
Form SC 13G/A Manchester United plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Jun 30
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Jun 30
-
Lansdowne Partners Austria GmbH Shows New 10.7% Stake in Alexza Pharma (ALXA)
-
Europe's Largest Hedge Fund Dumps Stake in Goldman (GS) as Growth Prospects Dwindle
-
Response Genetics (RGDX) Enters into 3M Common Private Placement

